Comprehensive analysis of Protégé's strengths and weaknesses based on real user feedback and expert evaluation.
Backed by $55M in Series A funding (including $30M extension led by a16z) signaling strong investor confidence and runway
Trusted by enterprise customers including Siemens Healthineers, validated by named testimonials from medical imaging leadership
Powers third-party benchmarks including Vals AI healthcare evaluations for clinical documentation and medical coding
Covers four distinct AI lifecycle stages (pre-training, post-training, fine-tuning, evaluation) rather than focusing on just one
Strong focus on uncontaminated evaluation data — datasets explicitly designed not to overlap with training data
Specializes in non-public proprietary data, addressing the actual bottleneck for frontier model improvements
6 major strengths make Protégé stand out in the coding agents category.
Enterprise-only pricing with no transparent tiers, making it inaccessible to indie developers or small startups
No self-serve data catalog — every engagement appears to require a sales conversation and custom data sourcing
Domain coverage is broad but uneven; healthcare appears far more mature than other verticals like spatial/physical intelligence
Relatively young company (Series A stage) with shorter operating history than incumbent data platforms like Scale AI
Limited public documentation about technical integration, dataset formats, or API access on the marketing site
5 areas for improvement that potential users should consider.
Protégé has potential but comes with notable limitations. Consider trying the free tier or trial before committing, and compare closely with alternatives in the coding agents space.
If Protégé's limitations concern you, consider these alternatives in the coding agents category.
Scale AI provides a data-centric infrastructure platform that accelerates AI development by combining human-in-the-loop data labeling with advanced automation. The platform supports the full AI data lifecycle—from annotation and curation to RLHF (Reinforcement Learning with Human Feedback) and model evaluation—serving enterprise customers including Meta, Microsoft, OpenAI, Toyota, and the U.S. Department of Defense. Scale's platform integrates with major ML frameworks and cloud providers (AWS, GCP, Azure), offers programmatic APIs for pipeline automation, and provides specialized workflows for computer vision, NLP, sensor fusion, and generative AI fine-tuning. Unlike competitors such as Labelbox or Snorkel AI, Scale differentiates through its managed workforce of over 240,000 contractors combined with proprietary quality-assurance algorithms, enabling high-throughput labeling at enterprise scale with configurable accuracy guarantees.
Protégé sources real-world, proprietary data across five primary domains: healthcare (including multimodal patient journey data, clinical documentation, and medical imaging), video, audio and speech, spatial and physical intelligence (including motion capture), and other industry-specific verticals. The platform supports all four stages of the AI development lifecycle, from massive diverse pre-training datasets to narrowly curated fine-tuning data and uncontaminated benchmark datasets. Unlike public scrape-based corpora, Protégé focuses specifically on private and proprietary data that is not otherwise available.
Protégé uses enterprise pricing that is not published on its website, meaning all engagements require direct contact with their sales and partnerships team. Pricing is presumably tailored to the volume, modality, and exclusivity of the data being licensed, as well as the scope of the consultative work needed to source and prepare it. This model is consistent with other premium AI data platforms targeting frontier labs and enterprise customers, though it makes the platform inaccessible to smaller teams and individual researchers. Prospective buyers should expect a custom quote process rather than a public pricing page.
Protégé operates under the corporate name Protege Health, Inc. and is headquartered at 169 Madison Ave, New York, NY. The company announced a $25 million Series A in February 2026 to expand its AI training data platform, followed by a $30 million Series A extension led by Andreessen Horowitz (a16z), bringing total Series A funding to approximately $55 million. The extension was driven by rapid adoption across healthcare, media, audio, motion capture, and other verticals as AI companies increasingly need high-quality, non-public data.
Based on our analysis of 870+ AI tools, Protégé differs from labeling-first platforms like Scale AI, Labelbox, and SuperAnnotate by focusing on data sourcing rather than annotation of existing data. Its core value proposition is connecting model builders with genuinely proprietary, non-public data held by hospitals, studios, and enterprises, with rights and provenance protections built in. Customer testimonials describe Protégé as a hands-on internal partner that helps identify the right data for specific problems, rather than a self-serve data catalog. This makes it more comparable to a specialized data brokerage than to a labeling tools vendor.
Yes — Protégé runs a dedicated 'For Data Providers' program that allows organizations holding proprietary datasets or content to generate revenue by licensing that data to AI builders. The platform emphasizes maintaining clear rights protections and provenance tracking throughout the exchange, which is particularly important for regulated domains like healthcare. Data providers can participate across the same five domains the platform serves: healthcare, video, audio and speech, spatial and physical intelligence, and other domains. This two-sided marketplace model is one of the platform's distinguishing features compared to pure-buy-side data vendors.
Consider Protégé carefully or explore alternatives. The free tier is a good place to start.
Pros and cons analysis updated March 2026